112 related articles for article (PubMed ID: 1936899)
1. Chronic administration of nicotine fails to alter the MPTP-induced neurotoxicity in mice.
Fung YK; Fiske LA; Lau YS
Gen Pharmacol; 1991; 22(4):669-72. PubMed ID: 1936899
[TBL] [Abstract][Full Text] [Related]
2. Diethyldithiocarbamate potentiates the neurotoxicity of in vivo 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and of in vitro 1-methyl-4-phenylpyridinium.
Miller DB; Reinhard JF; Daniels AJ; O'Callaghan JP
J Neurochem; 1991 Aug; 57(2):541-9. PubMed ID: 1649252
[TBL] [Abstract][Full Text] [Related]
3. Effects of nicotine on 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine-induced depression of striatal dopamine content and spontaneous locomotor activity in C57 black mice.
Gao ZG; Cui WY; Zhang HT; Liu CG
Pharmacol Res; 1998 Aug; 38(2):101-6. PubMed ID: 9721596
[TBL] [Abstract][Full Text] [Related]
4. Behavioral and biochemical effects of nicotine in an MPTP-induced mouse model of Parkinson's disease.
Sershen H; Hashim A; Lajtha A
Pharmacol Biochem Behav; 1987 Oct; 28(2):299-303. PubMed ID: 3500479
[TBL] [Abstract][Full Text] [Related]
5. EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice: role of oxidative stress.
Rojas P; Serrano-García N; Mares-Sámano JJ; Medina-Campos ON; Pedraza-Chaverri J; Ogren SO
Eur J Neurosci; 2008 Jul; 28(1):41-50. PubMed ID: 18662333
[TBL] [Abstract][Full Text] [Related]
6. Swim-test as a function of motor impairment in MPTP model of Parkinson's disease: a comparative study in two mouse strains.
Haobam R; Sindhu KM; Chandra G; Mohanakumar KP
Behav Brain Res; 2005 Sep; 163(2):159-67. PubMed ID: 15941598
[TBL] [Abstract][Full Text] [Related]
7. Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a radical scavenger, prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the substantia nigra but not the striatum.
Kawasaki T; Ishihara K; Ago Y; Baba A; Matsuda T
J Pharmacol Exp Ther; 2007 Jul; 322(1):274-81. PubMed ID: 17429058
[TBL] [Abstract][Full Text] [Related]
8. Novel sites of action for deprenyl in MPTP-parkinsonism: metabolite-mediated protection against striatal neurotoxicity and suppression of MPTP-induced increase of dopamine turnover in C57BL mice.
Sziráki I; Kardos V; Patthy M; Gaál J; Arányi P; Kollár E; Tömösközi Z; Király I
Prog Brain Res; 1995; 106():155-71. PubMed ID: 8584651
[No Abstract] [Full Text] [Related]
9. Consequences of manganese administration for striatal dopamine and motor behavior in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-exposed C57BL/6 mice.
Dodd CA; Bloomquist JR; Klein BG
Hum Exp Toxicol; 2013 Aug; 32(8):865-80. PubMed ID: 23263854
[TBL] [Abstract][Full Text] [Related]
10. Nicotine enhances 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity.
Behmand RA; Harik SI
J Neurochem; 1992 Feb; 58(2):776-9. PubMed ID: 1445501
[TBL] [Abstract][Full Text] [Related]
11. Synthetic bovine proline-rich-polypeptides generate hydroxyl radicals and fail to protect dopaminergic neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity in mice.
Knaryan VH; Samantaray S; Varghese M; Srinivasan A; Galoyan AA; Mohanakumar KP
Neuropeptides; 2006 Aug; 40(4):291-8. PubMed ID: 16712929
[TBL] [Abstract][Full Text] [Related]
12. Effect of chronic oral nicotine on dopaminergic function in the MPTP-treated mouse.
Sershen H; Hashim A; Wiener HL; Lajtha A
Neurosci Lett; 1988 Nov; 93(2-3):270-4. PubMed ID: 3266524
[TBL] [Abstract][Full Text] [Related]
13. Effect of chronic administration of magnesium sulfate on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice.
Tariq M; Khan HA; al Moutaery K; al Deeb SM
Pharmacol Toxicol; 1998 May; 82(5):218-22. PubMed ID: 9646326
[TBL] [Abstract][Full Text] [Related]
14. Effect of nicotine and amphetamine on the neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mice.
Sershen H; Mason MF; Reith ME; Hashim A; Lajtha A
Neuropharmacology; 1986 Nov; 25(11):1231-4. PubMed ID: 3491964
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effect of kaempferol against a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease.
Li S; Pu XP
Biol Pharm Bull; 2011; 34(8):1291-6. PubMed ID: 21804220
[TBL] [Abstract][Full Text] [Related]
16. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity: partial protection against striato-nigral dopamine depletion in C57BL/6J mice by cigarette smoke exposure and by beta-naphthoflavone-pretreatment.
Shahi GS; Das NP; Moochhala SM
Neurosci Lett; 1991 Jun; 127(2):247-50. PubMed ID: 1881637
[TBL] [Abstract][Full Text] [Related]
17. [Protective effect of nicotinamide in a mouse Parkinson's disease model].
Xu J; Xu SQ; Liang J; Lu Y; Luo JH; Jin JH
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2012 Mar; 41(2):146-52. PubMed ID: 22499510
[TBL] [Abstract][Full Text] [Related]
18. Effect of acetyl-L-carnitine on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity.
Harik SI; Hritz MA
Biochem Pharmacol; 1993 May; 45(10):2170-2. PubMed ID: 8512600
[TBL] [Abstract][Full Text] [Related]
19. Neonatal exposure to paraquat or MPTP induces permanent changes in striatum dopamine and behavior in adult mice.
Fredriksson A; Fredriksson M; Eriksson P
Toxicol Appl Pharmacol; 1993 Oct; 122(2):258-64. PubMed ID: 8212007
[TBL] [Abstract][Full Text] [Related]
20. Depletion of striatal dopamine by the N-oxide of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Lau YS; Fung YK; Trobough KL; Cashman JR; Wilson JA
Neurotoxicology; 1991; 12(2):189-99. PubMed ID: 1956580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
